Compound ID | 1851
Synonym(s): Sisomycin | rickamicin | antibiotic 6640
Class: Aminoglycoside
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Inhibits protein synthesis by binding to the 30S subunit of the bacterial ribosome. Active against Gram-positive and Gram-negative bacteria |
| Description: | Micromonospora natural product. Used for topical application |
| Institute where first reported: | Merck Sharp & Dohme LLC |
| Year first mentioned: | 1950 |
| Highest developmental phase: | Phase 4 (NCT00202891) |
| Development status: | Inactive |
| Reason Dropped: | Withdrawn during clinical trial |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/36119 |
| Guide to Pharmacology: | sisomicin |
| Citations: |
|